Traditional Chinese medicine composition for treating benign prostatic hyperplasia

Abstract

The invention discloses a traditional Chinese medicine composition for treating benign prostatic hyperplasia. The traditional Chinese medicine composition is prepared from 10 g of radix semiaquilegiae, 15 g of cowherb seed, 10 g of peach kernel, 6 g of safflower, 10 g of herba eupatorii, 15 g of herba patriniae, 15 g of radix cyathulae, 10 g of herba lycopi, 15 g of polygonum aviculare, 15 g of polyporus umbellatus, 3 g of tetrapanax papyriferus, 10 g of common fenugreek seed, 3 g of cinnamon, 6 g of ephedra, 10 g of semen brassicae and 15 g of dandelion. The traditional Chinese medicine composition mainly adopts herbaceous plants and achieves the effects of inducing diuresis for treating stranguria, reducing swelling and removing stasis and tonifying kidney and promoting qi circulation through scientific and reasonable compatibility, so that the purpose of treating benign prostatic hyperplasia is achieved, the clinical effect is outstanding, patients are satisfied, and no obvious side effect exists.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine formulations, in particular to a traditional Chinese medicine composition for treating benign prostatic hyperplasia. Background technique [0002] Benign prostatic hyperplasia mainly causes urination disorders in middle-aged and elderly men, and clinical symptoms such as waiting for urination, thinning of urine lines, intermittent urination, nocturia, and post-urination dripping are the main symptoms. In severe cases, acute urinary retention may occur. Western medicine treats this disease. Most of them take oral 5α-reductase inhibitors + α-blockers, and 5α-reductase inhibitors have the potential to reduce male libido and cause sexual dysfunction, and α-blockers have the risk of causing hypotension in patients. [0003] Therefore, there is a need for a pure traditional Chinese medicine compound composition that can have a good therapeutic effect on benign prostatic hyperplasia,...

AI Technical Summary

Problems solved by technology

[0002] Benign prostatic hyperplasia mainly causes urination disorder in middle-aged and elderly men. The clinical manifestations are waiting to urinate, thinning urine line, intermittent urination, increased nocturia, post-urination dribbling and other symptoms. In severe cases, acute urinary retention may also occur; Western medicine treats this disease Most of them take oral 5α-reductase inhibitors + α-receptor blockers, and 5α-reductase inhibitors have the potential to reduce male libido and cause sexual dysfunction, and α-receptor blockers have the risk of causing hypotension in patients